Publications by authors named "Nicolas Janus"

Claim this Profile
H
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations.
Nicolas Janus, Pierre-Yves Desplanques

Int J Clin Pharm· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis.
Corinne Frere, Carme Font, Francis Esposito, Benjamin Crichi, Philippe Girard, Nicolas Janus

Support Care Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Renal toxicity of anticancer drugs].
Blandine Aloy, Nicolas Janus, Corine Isnard-Bagnis, Gilbert Deray, Vincent Launay-Vacher

Nephrol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
Corinne Frere, Benjamin Crichi, Manon Lejeune, Jean-Philippe Spano, Nicolas Janus

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Non-iodinated contrast media nephrotoxicity].
Nicolas Janus, Vincent Launay-Vacher, Gilbert Deray

Nephrol Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis.
Nicolas Janus, Vincent Launay-Vacher

Expert Opin Drug Metab Toxicol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Course of chronic kidney disease in French patients.
Nicolas Janus, Vincent Launay-Vacher, Laurent Juillard, Gilbert Deray, Thierry Hannedouche

Clin Kidney J· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Renovascular effects of antiangiogenic drugs].
Gilbert Deray, Nicolas Janus, Blandine Aloy, Vincent Launay-Vacher

Bull Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?
Blandine Aloy, Imane Tazi, Corinne Isnard Bagnis, Marion Gauthier, Nicolas Janus

AIDS Rev· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Reply to the article Non-VKA oral anticoagulants: an update for the clinical biologists].
Nicolas Janus, Blandine Aloy, Gilbert Deray, Vincent Launay-Vacher

Ann Biol Clin (Paris)· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from the LIDO anemia survey: adherence to EORTC guidelines in cancer patients in France.
Vincent Launay-Vacher, Nicolas Janus, Gilbert Deray, Florian Scotté

Support Care Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal insufficiency and cancer treatments.
Vincent Launay-Vacher, Nicolas Janus, Gilbert Deray

ESMO Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Drugs in End-Stage Kidney Disease Patients.
Nicolas Janus, Vincent Launay-Vacher

Semin Dial· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria].
Vincent Launay-Vacher, Nicolas Janus, Philippe Beuzeboc, Catherine Daniel, Isabelle Ray-Coquard

Bull Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
Sabine Amet, Jean-Pierre Bronowicki, Dominique Thabut, Fabien Zoulim, Marc Bourliere, Nicolas Janus

Liver Int· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study.
Nicolas Janus, Vincent Launay-Vacher, Laurent Sebbag, Philippe Despins, Eric Epailly

Transpl Int· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New therapies for hepatitis C: considerations in patients with renal impairment.
Sarah Zimner-Rapuch, Nicolas Janus, Gilbert Deray, Vincent Launay-Vacher

Drugs· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients.
Vincent Launay-Vacher, Sarah Zimner-Rapuch, Nicolas Poulalhon, Thibault Fraisse, Valérie Garrigue, Nicolas Janus

Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.
Sabine Amet, Vincent Launay-Vacher, Olivier Clément, Camille Frances, Aurore Tricotel, Nicolas Janus

Invest Radiol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.
Nicolas Janus, Florian Scotte, Jean-Baptiste Rey, Sabine Amet, Laurence Rouillon

Support Care Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malaria prophylaxis in patients with renal impairment: a review.
Sabine Amet, Sarah Zimner-Rapuch, Vincent Launay-Vacher, Nicolas Janus, Gilbert Deray

Drug Saf· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary hypertension: use of oral drugs in patients with renal insufficiency.
Sarah Zimner-Rapuch, Sabine Amet, Nicolas Janus, Gilbert Deray, Vincent Launay-Vacher

Clin Drug Investig· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Letter on the article: "Kidney and HIV infection"].
Sarah Zimner-Rapuch, Nicolas Janus, Sabine Amet, Gilbert Deray, Vincent Launay-Vacher

Presse Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Risk of cancer in patients following chronic dialysis and kidney graft].
Nicolas Janus, Vincent Launay-Vacher, Jean-Marc Ferrero, Juliette Thariat

Bull Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[How to adjust the dose of drugs in chronic kidney disease?].
Vincent Launay-Vacher, Nicolas Janus, Sarah Zimner-Rapuch, Sabine Amet, Gilbert Deray

Rev Prat· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis